These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20147723)

  • 1. How innate immunity can inhibit the release of HIV-1 from infected cells.
    Guatelli J
    N Engl J Med; 2010 Feb; 362(6):553-4. PubMed ID: 20147723
    [No Abstract]   [Full Text] [Related]  

  • 2. Tetherin is as tetherin does.
    Hammonds J; Spearman P
    Cell; 2009 Oct; 139(3):456-7. PubMed ID: 19879831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetherin inhibits HIV-1 release by directly tethering virions to cells.
    Perez-Caballero D; Zang T; Ebrahimi A; McNatt MW; Gregory DA; Johnson MC; Bieniasz PD
    Cell; 2009 Oct; 139(3):499-511. PubMed ID: 19879838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles.
    Fitzpatrick K; Skasko M; Deerinck TJ; Crum J; Ellisman MH; Guatelli J
    PLoS Pathog; 2010 Mar; 6(3):e1000701. PubMed ID: 20221443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane.
    Hammonds J; Wang JJ; Yi H; Spearman P
    PLoS Pathog; 2010 Feb; 6(2):e1000749. PubMed ID: 20140192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Lassa and Marburg virus production by tetherin.
    Sakuma T; Noda T; Urata S; Kawaoka Y; Yasuda J
    J Virol; 2009 Mar; 83(5):2382-5. PubMed ID: 19091864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperation of the Ebola Virus Proteins VP40 and GP
    Rizk MG; Basler CF; Guatelli J
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCA2/Rabring7 promotes tetherin-dependent HIV-1 restriction.
    Miyakawa K; Ryo A; Murakami T; Ohba K; Yamaoka S; Fukuda M; Guatelli J; Yamamoto N
    PLoS Pathog; 2009 Dec; 5(12):e1000700. PubMed ID: 20019814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV/AIDS: virus kept on a leash.
    Göttlinger HG
    Nature; 2008 Jan; 451(7177):406-8. PubMed ID: 18200012
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes.
    Iwabu Y; Fujita H; Kinomoto M; Kaneko K; Ishizaka Y; Tanaka Y; Sata T; Tokunaga K
    J Biol Chem; 2009 Dec; 284(50):35060-72. PubMed ID: 19837671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.
    Van Damme N; Goff D; Katsura C; Jorgenson RL; Mitchell R; Johnson MC; Stephens EB; Guatelli J
    Cell Host Microbe; 2008 Apr; 3(4):245-52. PubMed ID: 18342597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism.
    Douglas JL; Viswanathan K; McCarroll MN; Gustin JK; Früh K; Moses AV
    J Virol; 2009 Aug; 83(16):7931-47. PubMed ID: 19515779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The great escape: viral strategies to counter BST-2/tetherin.
    Douglas JL; Gustin JK; Viswanathan K; Mansouri M; Moses AV; Früh K
    PLoS Pathog; 2010 May; 6(5):e1000913. PubMed ID: 20485522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C-Terminal End of HIV-1 Vpu Has a Clade-Specific Determinant That Antagonizes BST-2 and Facilitates Virion Release.
    Sharma S; Jafari M; Bangar A; William K; Guatelli J; Lewinski MK
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of the Cytoplasmic Determinants of Vpu to the Expansion of Virus-Containing Compartments in HIV-1-Infected Macrophages.
    Leymarie O; Lepont L; Versapuech M; Judith D; Abelanet S; Janvier K; Berlioz-Torrent C
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BST-2 restricts IAV release and is countered by the viral M2 protein.
    Hu S; Yin L; Mei S; Li J; Xu F; Sun H; Liu X; Cen S; Liang C; Li A; Guo F
    Biochem J; 2017 Feb; 474(5):715-730. PubMed ID: 28087685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetherin restricts productive HIV-1 cell-to-cell transmission.
    Casartelli N; Sourisseau M; Feldmann J; Guivel-Benhassine F; Mallet A; Marcelin AG; Guatelli J; Schwartz O
    PLoS Pathog; 2010 Jun; 6(6):e1000955. PubMed ID: 20585562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tethered virions are intermediates in the assembly and release of HIV-1 particles.
    Karetnikov A; Suomalainen M
    Virology; 2010 Nov; 407(2):289-95. PubMed ID: 20850859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
    Neil SJ; Zang T; Bieniasz PD
    Nature; 2008 Jan; 451(7177):425-30. PubMed ID: 18200009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Membrane-Associated Restriction Factors and Their Counteraction by HIV-1 Accessory Proteins.
    Ramirez PW; Sharma S; Singh R; Stoneham CA; Vollbrecht T; Guatelli J
    Cells; 2019 Sep; 8(9):. PubMed ID: 31480747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.